Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAerpio Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/29/2023 | Q3 2023 | -$0.86 | $1.23 M | |||
| 06/29/2023 | Q2 2023 | -$0.06 | $980,000 | |||
| 03/30/2023 | Q1 2023 | -$0.40 | $796,000 | |||
| 12/30/2022 | Q4 2022 | -$0.29 | $1.05 M | |||
| 09/29/2022 | Q3 2022 | -$0.24 | $1.34 M | |||
| 06/29/2022 | Q2 2022 | -$0.26 | $1.88 M | |||
| 03/30/2022 | Q1 2022 | -$0.30 | $1.24 M | |||
| 12/30/2021 | Q4 2021 | -$0.23 | $989,000 | |||
| 09/29/2021 | Q3 2021 | -$0.22 | $1.25 M | |||
| 06/29/2021 | Q2 2021 | -$0.25 | $1.17 M | |||
| 03/30/2021 | Q1 2021 | -$0.27 | $1.07 M | |||
| 12/30/2020 | Q4 2020 | -$0.36 | $504,000 | |||
| 09/29/2020 | Q3 2020 | -$0.31 | $288,000 | |||
| 06/29/2020 | Q2 2020 | -$0.26 | $31,000 | |||
| 03/30/2020 | Q1 2020 | -$0.49 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.48 | $0 | |||
| 09/29/2019 | Q3 2019 | -$0.73 | $0 | |||
| 06/29/2019 | Q2 2019 | -$0.69 | $0 | |||
| 03/30/2019 | Q1 2019 | -$0.80 | $0 | |||
| 12/30/2018 | Q4 2018 | -$0.24 | $0 |
Aerpio Pharmaceuticals, Inc. Earnings: FAQ's
How can I listen to Aerpio Pharmaceuticals, Inc.'s earnings conference
call?
The conference call for Aerpio Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
How can I read Aerpio Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Aerpio Pharmaceuticals, Inc.'s latest earnings report can be read online.
How much revenue does Aerpio Pharmaceuticals, Inc. generate each year?
Aerpio Pharmaceuticals, Inc. (:ARPO) has a recorded annual revenue of $5.51 M.
How much profit does Aerpio Pharmaceuticals, Inc. generate each year?
Aerpio Pharmaceuticals, Inc. (:ARPO) has a recorded net income of $5.51 M. Aerpio Pharmaceuticals, Inc. has generated $-1.08 earnings per share over the last four quarters.
What is Aerpio Pharmaceuticals, Inc.'s price-to-earnings ratio?
Aerpio Pharmaceuticals, Inc. (:ARPO) has a price-to-earnings ratio of -2.29 and price/earnings-to-growth ratio is 0.04.